Skip to Main Content

Paper Details

Molecular Profiling of Exceptional Responders to Cancer Therapy.
Oncologist
16
2021
142-gene panel, Cancer, DNA, EPHA5, EPHA5 nonsynonymous mutation, Messenger RNA, Tumor, antitumor, bladder, kidney, breast, lung, ovarian, uterine, and colon cancers, cancer, genes, metastatic, metastatic cancers, patients, tumor
Author NameAffiliation
Michael SlifkerFox Chase Cancer Center
Qing-Rong ChenCenter for Biomedical Informatics and Information Technology, National Cancer Institute, National Institutes of Health
Qing-Rong ChenCenter for Biomedical Informatics and Information Technology, National Cancer Institute, National Institutes of Health
  • 1 - 3

Datasets

Release 1.2